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Abstract 
Pregnancy introduces a vast array of hormonal fluctuations which progress into the postpartum 
period. The thyroid gland responds to pregnancy by increasing thyroid hormone production in 
response to the growing fetus. In the postpartum period, thyroid hormone dysfunction is the 
thyroid transitioning from the suppressed state during pregnancy in an attempt to revert to a 
euthyroid state. This transition in the woman is evidenced by thyroid stimulating hormone (TSH) 
levels >10mU/L. Levels of TSH in the postpartum period impact regulatory hormones of 
lactation which may lead to difficulties with milk supply. It is estimated that Postpartum 
thyroiditis (PPT) occurs in 7-10% of postpartum women, with variations regarding genetic 
factors influencing thyroid disease (Ablovich, Amino, Barbour, Cobin, Degroot & Glinoer, 
2007). It is recommended by the Center for Disease Control and Prevention (CDC) (2017) that 
infants be exclusively breastfed for the first six months after birth to achieve optimal growth, 
development, and health. The postpartum period compiles a multifactorial initiation of 
physiologic adaptations in the female body, most notable being lactation and the practice of 
breastfeeding. The postpartum female who has TSH levels >10mU/L is indicative of a 
hypothyroid state and requires pharmacological management and further monitoring. Adequate 
treatment with Levothyroxine to a euthyroid state restores hormones of lactation and positively 
impacts milk supply. It is important for the health care provider to be aware of the clinical 
evaluation and management of hypothyroidism in the postpartum period and how this may affect 










Effective management of thyroid disease in the postpartum period is important for  
 
optimal maternal and fetal health. A hypothyroid state in the postpartum female alters the  
 
functioning of prolactin and oxytocin involved in milk production and supply by negatively  
 
influencing their release and feedback from the hypothalamic-pituitary axis (HPA). Lactation  
 
and breastfeeding are supported as providing emotional and physical benefits to the mother and  
 
infant. Breastfeeding has long been reviewed as the best source of nutrition and a reliable  
 
indicator of growth prediction for the newborn. Infants who are breastfed are less likely to be  
 
diagnosed with asthma, obesity, type 2 diabetes, ear and respiratory infections, sudden infant  
 
death syndrome, and gastrointestinal infections (CDC, 2019). Not only are there benefits to the  
 
newborn, but the exclusively breastfeeding mother may also benefit from breastfeeding. The  
 
Center for Disease Prevention and Control (2019) suggests breastfeeding may help lower a  
 
women’s risk of high blood pressure, type 2 diabetes, ovarian cancer, and breast cancer.  
 
Disruptions in one’s ability to adequately lactate may be related to endocrine changes in  
 
the postpartum female. Specifically, fluctuations in excess levels of TSH during the postpartum  
 
period have a negative impact on breastfeeding when desired. Understanding of the hormonal  
 
feedback mechanisms is pertinent to further discussing alterations in the neuroendocrine changes  
 
observed in the postpartum female. According to Stuebe et al. (2015) disorders of thyroid  
 
hormone have been associated with low milk supply in the lactating woman. Hormonal  
 
regulation is pertinent to assess in the presenting female experiencing challenges with  
 
breastfeeding. The purpose of this report is to address the management of lactation disturbances  
 
in the breastfeeding female by assessing thyroid function, explicitly addressing elevated levels of  
 
TSH in the postpartum female.  
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Case Report  
 
The case being presented is a 32-year-old female (name CT) who is otherwise healthy  
 
and comes to the primary care provider with symptoms of fatigue, dry skin, difficulty  
 
breastfeeding, and intermittent constipation. CT reports she is three months postpartum of  
 
delivering a healthy baby boy and has felt physical symptoms of fatigue more than usual.  CT  
 
has been battling constant dry skin, is having trouble breastfeeding, and has been experiencing  
 
constipation at times. Her newborn is at a healthy weight for age and length. CT includes that she  
 
was having difficulty breastfeeding with her newborn upon delivery and at home and has been  
 
formula feeding for the last three weeks. CT states her fatigue is “more pronounced than ever,  
 
even with my other 2 children I wasn’t this tired all the time postpartum.” CT endorses using  
 
lotions for her dry skin to no avail. She also states the constipation doesn’t bother her much, and  
 
her Culturelle Probiotic helps keep her bowel movements regular. She notes the only  
 
medications she takes consist of a Women’s Prenatal Multivitamin and Culturelle Probiotic  
 
daily. CT reports the fatigue and inability to breastfeed are interfering with her ability to attend  
 
to her family. CT also states, “I wonder if it’s my thyroid, my mom and sister are on medication  
 
for their thyroid, but my thyroid labs have always been normal.”  
 
Upon completing a review of systems, a physical exam includes the following pertinent  
 
positives: Bilateral forearm epidermis is dry. Notable for thin, brittle hair to her scalp. Delayed  
 
+1 deep tendon reflexes bilaterally to biceps, brachioradialis, patellar and Achilles tendons,  
 
mood tired and appears extensively fatigued. Labs completed with complete blood count and  
 
basic metabolic panel within normal limits. TSH notably high at 18.61mIU/L (normal level 0.4- 
 
4.0 mU/L) and Free T4 1.27 ng/dL (normal level 0.7-1.9 ng/dl) indicating a normal level. In  
 
reviewing previous lab results prior to her pregnancy, TSH levels were within normal ranges for  
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the last 8 years with no data recorded in the electronic record system prior to that time.  
 
Given CT’s presentation and supportive lab work, we discussed the diagnosis of  
 
Postpartum Thyroiditis (PPT), indicating a hypothyroid state. Today we will initiate  
 
Levothyroxine 50mcg PO daily 30 minutes before breakfast. She was reassured this is a safe  
 
medication to take if she attempts to breastfeed at home. CT has agreed to come back to the  
 
clinic in 6 weeks for a TSH recheck to assess need for dosing adjustments and evaluate  
 
improvement in symptoms. She was also encouraged to try Fish Oil 500mg tablet PO daily and  
 
introduce ground flaxseeds into her diet for management of dry skin. Difficulties with lactation  
 
were also discussed, and CT reports with her other two children she was able to breastfeed until  
 
18 months of age without difficulty. With her most recent pregnancy she states she was able to  
 
breastfeed after delivery for the first 2 months of being at home with her baby. Denies issues  
 
with latching onto the breast but states “I don’t feel like I have enough milk.” CT reports she met  
 
with a lactation nurse in the hospital after delivery and was successful with breastfeeding and  
 
utilizing the breast pump. In review of the literature, current research supports elevated in  
 
TSH (>10mU/L) being related to complications with lactation in the postpartum period.  
 
 CT’s physical presentation and current complaints of low milk supply, suspicion related  
 
to her thyroid function should be considered. Discussion with CT included the hormonal  
 
feedback mechanisms which occur with milk production and release, and how her elevated TSH  
 
levels may be playing a role in difficulties with lactation. CT is willing to attempt breastfeeding  
 
while starting on Levothyroxine with hopes of improvement in milk supply and release for her  
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Literature Review  
 
Pregnancy elicits many physiological changes in the female body from the time of  
conception through the postpartum period. Changes in metabolic functioning of hormones occur  
because of increased metabolic demands during both pregnancy and lactation (Arfuso, Fazio,  
Levanti, Rizzo, Di Pietro, Giudice, 2016). Gestation produces numerous metabolic alterations  
and suppressive states, especially with respect to the thyroid gland. The neuroendocrine  
adaptations such as elevated levels of TSH occurring in the postpartum female impacts  
mammary gland function by negatively interacting with the hormones of lactation (Campo Verde  
Arbocco, Sasso, Nasif, Hapon, & Jahn, 2015) as well as milk supply (Stuebe, Meltzer-Brody,  
Pearson, Pederson, & Grewen, 2015). Such hormonal interplay affects how the hormones of  
lactation appropriately supply and release milk for breastfeeding. Physical alterations which may  
accompany pregnancy and the postpartum period include but are not limited to: increased  
fatigue, nausea, vomiting, and healthy weight gain in relation to fetal number, size and the  
woman’s weight prior to pregnancy. Physical feelings experienced because of pregnancy and the  
postpartum period may also disguise an underlying disease process such as thyroid disease.  
Symptoms of fatigue, weight gain, irritability, and depression may resemble a mental health  
need, thyroid disease, or the postpartum female simply adapting to caring for an infant. It is  
important for the provider to understand the expected alterations which occur in the female  
throughout pregnancy and in the postpartum period. The following literature review will focus  
on the postpartum female who presents with a subjective report, physical exam, and lab work  
consistent with postpartum thyroiditis in the hypothyroid state.  
Post-Partum Thyroiditis (PPT) is the occurrence of thyroid dysfunction in the absence of  
 
a toxic thyroid nodule or thyrotoxin receptor antibodies in the first postpartum year in women  
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who were euthyroid prior to pregnancy (Muller, Drexhage, & Berghout, 2001). Post-Partum 
Thyroiditis has an autoimmune component which reflects the rebound of the thyroid gland after 
being in a suppressive state during pregnancy leading to inflammation of the thyroid gland and 
release of thyroid hormones into circulation (Yalamanchi & Cooper, 2015). Increases in thyroid 
hormone production in pregnancy result from fetal and maternal increases in iodine need and  
supplementation. PPT may occur in the postpartum individual who was otherwise euthyroid  
prior to and throughout her pregnancy (Alexander, Pearce, Brent, Brown, Chen, Dosiou,  
Grobman, Laurberg, Lazarus, Mandel, Peeters, & Sullivan, 2017).  
Post-Partum Thyroiditis most commonly presents in the postpartum female as an initial 
hyperthyroid state followed by hypothyroidism with a return to a euthyroid state by the end of 
the postpartum year (Qaseem, Snow, Owens, & Shekelle, 2010). Approximately 20-40% of 
women with PPT develop permanent primary hypothyroidism within 3-12 years (Stuckey, Kent, 
& Ward, 2010). Some individuals may experience symptoms consistent with isolated 
hypothyroidism in the postpartum period which may be hard to detect from normal variations in 
the postpartum woman given in the pronounced fatigue, impaired memory, and weight gain 
consistent with pregnancy. According to Alexander et al., (2017) PPT reflects the rebounding 
mechanism within the thyroid gland in the postpartum period following the relative immune 
suppression occurring in pregnancy.  
In the early stages of a healthy pregnancy, placental human chorionic gonadotropin 
(hCG) stimulates thyroid hormone secretion, which naturally decreases maternal TSH 
concentrations (Alexander et al., 2017).  This mechanism reflects the natural rebounding of the 
immunosuppressed state of the thyroid gland throughout pregnancy. Post-Partum Thyroiditis 
reflects the adaptions in the thyroid gland from a gestational state to the postpartum period.  
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It has been demonstrated that elevated TSH concentrations (>10mU/L) in the postpartum  
female exhibit changes with milk production and let down, thereby affecting one’s ability to  
lactate. Maternal hormone fluctuation, alterations in breast anatomy, difficulties with infant latch 
and feeding patterns influence the woman’s ability to lactate (Steube et al., 2015). Low milk 
supply is cited by many women as the primary reason for discontinuing to breastfeed.  
The interplay of hormones involved in lactation and milk management affect milk  
initiation and ongoing milk production, also known as galactopoesis (Sriraman, 2017).  
Lactation is the process of continued secretion of milk and requires removal of milk and  
stimulation of the female’s nipple. Reduced milk production may be affected by many internal  
and external factors including hormonal imbalances, interactions of certain medications the  
individual may be taking, improper development of the breast during pregnancy, or previous  
breast surgery or radiation treatment (Spencer, Abrams, & Hoppin, 2017).  
There are significant neuroendocrine adjustments which promote and maintain lactation  
in the postpartum period. These include alterations in the primary hormones involved in lactation  
including prolactin and oxytocin which are regulated through a negative feedback mechanism in  
the HPA. Disruptions to the HPA such as elevations in TSH >10mU/L indicating a hypothyroid  
state negatively alters feedback mechanisms in milk supply and hinders the ability to breastfeed.  
Interestingly, animal research studies have shown a relationship is found in relation to TSH 
values and positive milk yield which suggests the role of the thyroid gland on the maintenance of 
lactogenesis (Fiore, Arfuso, Gianesella, Vecchio, Morgante, Mazzotta, Badon, Rossi, Bedin, & 
Piccione, 2018). Research proving such a relationship in humans has yet to be  
conducted.  
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Further assessment in thyroid dysfunction also include discussing the alterations in  
lactation experienced by the female. This provides opportunity to discuss her goals of feeding the  
infant and restoring her milk supply if able to return with treatment to a euthyroid state (Kellams,  
Harrel, Omage, Gregory, Rosen-Carol, 2017). As mentioned, it may be difficult to determine  
PPT in the form of hypothyroidism in the postpartum female as the clinical symptoms can  
mimic the typical fatigue following delivery and caring for a newborn. Careful assessment and  
knowledge of the postpartum female’s adaptations in endocrine functioning is critical to  
diagnosis and management of PPT. Women in the postpartum period who present to the primary  
care provider with decreased milk supply should heighten the providers awareness to the  
possibility of PPT and appropriately include TSH screening in her evaluation.  
There are differences of opinion in how to screen for thyroid disease during pregnancy  
and in the postpartum period. Guidelines have been established by the American Thyroid  
Association (ATA) for recommendations of monitoring thyroid function during pregnancy and in  
the postpartum period. Revisions to the ATA guidelines for thyroid monitoring in pregnancy and  
the postpartum period has not been updated and should be noted for further research needs.  
Indications for thyroid testing before and during pregnancy include presence of a goiter, family  
history of autoimmune thyroid disease, on current thyroid therapy, or history of high-dose neck  
radiation, PPT, previous delivery of an infant with thyroid disease, type I diabetes mellitus, or an  
autoimmune disorder (De Groot, Abalovich, & Alexander, 2012). Those who may be at higher  
risk for developing PPT include those with a family history of thyroid disease, smokers, personal  
history or autoimmune thyroid disease, those with positive TPO antibodies during early  
pregnancy, and those needing Levothyroxine replacement during pregnancy (Nochev, Argatska,  
Pehlivanov, & Orbetzova, 2017).  
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Assessing one’s risk factors for thyroid disease in pregnancy or the postpartum period  
requires knowledge of one’s family history and current health status. The ACOG recommends  
testing high-risk women who are symptomatic or have a personal history of an autoimmune  
disease (American College of Obstetrics and Gynecology, 2007), and no current revisions have  
been made to their recommended screening guidelines. In contrast, the Endocrine Society  
supports testing for thyroid dysfunction in women 30 years of age or older, with a family history  
of thyroid disease, presenting with signs and symptoms of thyroid disease, have a personal  
history of thyroid disease or thyroid surgery, have had prior neck irradiation, a positive thyroid  
peroxidase (TPO) antibody, history of autoimmune disease, infertility, history of miscarriage or  
preterm delivery, or residence in an iodine-deficient area (Degroot et al., 2012). The ATA  
recommendations are similar to screening recommendations to that of the Endocrine Society, but  
also includes screening women with body mass index (BMI) >40kg/m2 and women who have  
used amiodarone, lithium, or received recent iodinated contrast (Stagnaro-Green, 2011). With  
differences in screening recommendations during the state of pregnancy, opinions of how to  
assess thyroid dysfunction on the postpartum state have been well established. An individual  
without significant risk factors for PPT but who present to the providers office in the postpartum  
period with significant symptoms consistent with hypothyroidism should have their TSH and  
thyroxine (T4) level drawn to assess the need for thyroid hormone supplementation.  
Diagnosis of hypothyroidism in the postpartum period is evidence by elevated TSH  
values >10mU/L in women who are also reporting significant symptoms and troubles with  
lactation (Stagnaro-Green, 2012) and it is recommended that they should be treated with  
Levothyroxine. Duration of therapy is not distinguished given that postpartum hypothyroidism  
may be transient or lead to overt hypothyroidism. Recommendations have been made to wean  
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the individual off their Levothyroxine after 6-12 months of treatment unless the woman is  
pregnant, attempting pregnancy, or continuing to breastfeed (Stagnaro-Green, 2012). The goal of  
postpartum hypothyroidism treatment is lowering TSH to a euthyroid state (TSH of 0.4- 
4.0mU/L), which typically occurs within 6-12 months after the initial diagnosis. Research  
suggests up to 30% of women never recover from the initial hypothyroid phase as evidenced by  
an increasing TSH level while the individual is taken off their Levothyroxine. This persistent rise  
in TSH indicates permanent hypothyroidism (Aziz, 2005). Such individuals will require long  
term T4 replacement. Some research suggests being able to detect the severity of the initial  
hypothyroid postpartum episode and the predicted development of permanent hypothyroidism  
using antithyroid peroxidase antibodies for assessment. For example, Aziz (2010) reports women  
with very elevated initial TSH values (50-100mU/L) and presence of high titers of antithyroid  
peroxidase antibodies suggest the possibility of permanent hypothyroidism. After initiation of  
Levothyroxine, thyroid function should be rechecked in six weeks. For women who have  
recovered from PPT and been weaned from medication therapy, serum TSH levels should be  
measured annually for the following 5-10 years after initial diagnosis (Degroot, et al., 2012).  
Individuals who have been diagnosed with PPT are at an increased risk of overt hypothyroidism  
indefinitely (Abalovich et al., 2007). Proper monitoring of one’s TSH after the occurrence of  
PPT provides measurement of adequate thyroid functioning and surveillance of isolated  
hypothyroidism. 
 In summary, the performance of the thyroid gland fluctuates in the postpartum period due  
to hormonal alterations occurring after delivery of the infant and onset of lactation. The shift in  
thyroid hormone, specifically elevated TSH levels play an important role in negatively impacting 
hormones of lactation, namely prolactin and oxytocin. Such adjustments in TSH and hormones  
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of lactation reduce milk supply and may inhibit the woman’s ability to breastfeed. Being aware  
of the neuroendocrine relationship between TSH and hormones of lactation allows health care  
providers to assess for PPT when the female presents with lactation concerns and symptoms of  
hypothyroidism. Proper diagnosis and treatment of PPT should restore the postpartum female to  
a euthyroid state, allowing for return of proper lactation. 
Learning Points 
• The importance of understanding the relationship between hormones of lactation and 
thyroid function allowed for adequate assessment of TSH in the postpartum female 
presenting with the inability to breastfeed. 
• Pregnancy induces a suppressive state which can carry over into the postpartum period 
which alters hormonal feedback mechanisms required for lactation and decreasing milk 
supply. 
• The diagnosis of PPT is often challenging given its broad range of presenting symptoms. 
Providers should include hypothyroidism in their differential when working with this 
population. 
• Following recommended guidelines in screening women who plan to get pregnant and  
during pregnancy helps to distinguish those who are at risk for PPT. In the postpartum  
period, diagnostic levels of TSH >10mU/L in the woman presenting with symptoms of  
hypothyroidism who also report a decrease in milk supply are requirements for diagnosis 
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